# FDA Inspection 1018343 - Octapharma Plasma, Inc. - March 01, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/495a00f3-1d96-4a16-8960-6220450969fb
Source feed: FDA_Inspections

> FDA Inspection 1018343 for Octapharma Plasma, Inc. on March 01, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1018343
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2017-03-01
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1089185 - 2019-05-09](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/f87985e4-a3e3-46b7-b8b5-fedd7caade3e)
- [FDA Inspection 913755 - 2015-02-11](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/cf4d0376-a1be-4fb8-97fa-97da375c78b3)
- [FDA Inspection 853429 - 2013-10-31](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/7847416b-5f78-4aee-b7bb-c87c803977ea)

Company: https://www.globalkeysolutions.net/companies/octapharma-plasma-inc/c384ed6f-a544-42af-8073-ae590af7c2c4

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d